Shlobin OA - Search Results

1

Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.

Maron BA, Abman SH, Elliott CG, Frantz RP, Hopper RK, Horn EM, Nicolls MR, Shlobin OA, Shah SJ, Kovacs G, Olschewski H, Rosenzweig EB. Maron BA, et al. Among authors: shlobin oa. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1472-1487. doi: 10.1164/rccm.202012-4317SO. Am J Respir Crit Care Med. 2021. PMID: 33861689 Free PMC article.

2

Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.

Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Nathan SD, et al. Among authors: shlobin oa. Chest. 2007 Mar;131(3):657-663. doi: 10.1378/chest.06-2485. Chest. 2007. PMID: 17356077

3

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.

Nathan SD, Shlobin OA, Barnett SD, Saggar R, Belperio JA, Ross DJ, Ahmad S, Saggar R, Libre E, Lynch JP 3rd, Zisman DA. Nathan SD, et al. Among authors: shlobin oa. Respir Med. 2008 Sep;102(9):1305-10. doi: 10.1016/j.rmed.2008.03.022. Epub 2008 Jul 10. Respir Med. 2008. PMID: 18619825 Free PMC article.

4

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis.

Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD. Nathan SD, et al. Among authors: shlobin oa. Respir Med. 2010 Jul;104(7):1035-41. doi: 10.1016/j.rmed.2010.02.008. Epub 2010 Mar 2. Respir Med. 2010. PMID: 20199856 Free article.

5

Categorization and impact of pulmonary hypertension in patients with advanced COPD.

Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, Barnett SD, Nathan SD. Cuttica MJ, et al. Among authors: shlobin oa. Respir Med. 2010 Dec;104(12):1877-82. doi: 10.1016/j.rmed.2010.05.009. Epub 2010 Jun 14. Respir Med. 2010. PMID: 20547449 Free article.

6

Pulmonary hypertension secondary to interstitial lung disease.

Shlobin OA, Nathan SD. Shlobin OA, et al. Expert Rev Respir Med. 2011 Apr;5(2):179-89. doi: 10.1586/ers.11.11. Expert Rev Respir Med. 2011. PMID: 21510729 Review.

7

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation.

Shlobin OA, Nathan SD. Shlobin OA, et al. Eur Respir J. 2012 Jun;39(6):1520-33. doi: 10.1183/09031936.00175511. Epub 2012 Jan 12. Eur Respir J. 2012. PMID: 22241743 Free article. Review.

8

Management of right heart failure in the critically ill.

King C, May CW, Williams J, Shlobin OA. King C, et al. Among authors: shlobin oa. Crit Care Clin. 2014 Jul;30(3):475-98. doi: 10.1016/j.ccc.2014.03.003. Crit Care Clin. 2014. PMID: 24996606 Review.

9

Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD. Shin S, et al. Among authors: shlobin oa. Respir Med. 2014 Nov;108(11):1626-32. doi: 10.1016/j.rmed.2014.08.009. Epub 2014 Sep 2. Respir Med. 2014. PMID: 25225149 Free article.

10

Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.

Shlobin OA, Brown AW, Nathan SD. Shlobin OA, et al. Chest. 2017 Jan;151(1):204-214. doi: 10.1016/j.chest.2016.08.002. Epub 2016 Aug 20. Chest. 2017. PMID: 27554299 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page